Search details
1.
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts.
Blood
; 141(13): 1584-1596, 2023 03 30.
Article
in English
| MEDLINE | ID: mdl-36375120
2.
Medical Student Duty Hours and Shelf Performance: Is There a Correlation?
Am J Perinatol
; 2023 Jul 04.
Article
in English
| MEDLINE | ID: mdl-37230478
3.
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
Blood
; 136(1): 93-105, 2020 07 02.
Article
in English
| MEDLINE | ID: mdl-32202637
4.
Risk Factors for Adverse Maternal Outcomes following Expectantly Managed Preterm Prelabor Rupture of Membranes.
Am J Perinatol
; 39(8): 803-807, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34839477
5.
Beta-blocker and ACE-inhibitor dosing as a function of body surface area: From the HF-ACTION trial.
Am Heart J
; 233: 1-4, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33245905
Results
1 -
5
de 5
1
Next >
>>